NHIA Roundtables (4 - 25 Minute Rotations)

36. Operationalizing AI in Infusion: Governance, Risk, and Return

AI adoption in infusion is rarely a straight line and often exposes unexpected operational and governance gaps. This roundtable will facilitate a candid discussion on how infusion leaders can approach AI as a disciplined tool, verify and validate outputs before acting, and translate pilots into measurable financial and operational impact.
AI adoption in infusion is rarely a straight line and often exposes unexpected operational and governance gaps. This roundtable will facilitate a candid discussion on how infusion leaders can approach AI as a disciplined tool, verify and validate outputs before acting, and translate pilots into measurable financial and operational impact.

Learning Objectives

  • Identify where AI creates measurable financial impact in infusion, including revenue cycle, intake, and operations.
  • Distinguish high ROI AI use cases from low value experimentation.
  • Build a practical roadmap for piloting, measuring, and scaling AI in an infusion environment.
  • Speaker(s)

    Chris Hilger MS CEO
    SolisRx

                array(6) {
      [0]=>
      string(17) "Session Organizer"
      [1]=>
      string(19) "Symposium Organizer"
      [2]=>
      string(22) "Learning Lab Organizer"
      [3]=>
      string(13) "ISC Organizer"
      [4]=>
      string(16) "Industry Contact"
      [5]=>
      string(17) "Theater Organizer"
    }
                
    Speaker

    Share: